Approval to market a new stent system.  The device is indicated for improving coronary luminal diameter in the following:  Patients with symptomatic ischemic disease due to discrete de novo or restenotic native coronary arteries (length < 30 mm) with a reference vessel diameter of 3.0 to 4.0 mm.  Long term outcome (beyond 6 months) for this permanent implant is unknown at present.